🇺🇸 LGND — Ligand Pharmaceuticals Incorporated
Salud Compra fuertePrecio actual
306,20 USD
Máx. histórico
322,75
7 días
Split 1603:1000 del 02/11/2022
Caída desde máximo
-5,13%
Rango 52 semanas
175,89 – 326,63
Variación hoy
+2,41%
Cierre anterior
299,00
Rango de hoy
297,84 – 308,26
Volumen hoy
130.173
Peor caída histórica
-93,34%
06/03/2000 → 19/11/2008
Recuperado en 2694 días
Volatilidad anualizada ⓘ
59,76%
- Nombre completo
- Ligand Pharmaceuticals Incorporated
- Divisa
- USD
- Mercado
- NasdaqGM
- Sector
- Salud
- Industria
- Biotechnology
- Empleados
- 47
- PER ⓘ
- 122,97 (puede no estar actualizado)
- Dividend yield
- 0,00% (puede no estar actualizado)
- Precio objetivo analistas
- 351,33 USD (puede no estar actualizado)
- Primera cotización
- 18/11/1992
- Precio actualizado
- hace 22 horas
Ligand Pharmaceuticals Incorporated, a biopharmaceutical company, develops and licenses biopharmaceutical assets worldwide. It offers Pradefovir, Posaconazole, Voriconazole, CAPVAXIVE, NOXAFIL, MenFive, and ZELSUVMI for infectious disease; EVOMELA and KYPROLIS for multiple myeloma; FILSPARI for the treatment of immunoglobulin a nephropathy; PNEUMOSIL, a pneumococcal conjugate vaccine to help fight against pneumococcal pneumonia in children; and QARZIBA to treat neuroblastoma. The company also provides Teriparatide injection product for osteoporosis; RYLAZE, a recombinant erwinia asparaginase for acute lymphoblastic leukemia or lymphoblastic lymphoma in adult and pediatric patients; TZIELD, a CD3-directed antibody indicated to delay the onset of Stage 3 type 1 diabetes in adults and children aged 8 years and older with Stage 2 T1D; and VAXNEUVANCE for the prevention of invasive disease caused by streptococcus pneumoniae serotypes. In addition, it offers Duavee for menopause; Frovatriptan to treat Neurology; FYCOMPA and SESQUIENT for CNS; MEKINIST for cardiology; Nexterone, a captisol-enabled formulation of amiodarone; VEKLURY, an antiviral treatment for COVID-19; and Viviant for osteoporosis. Further, the company develops ACLX-002, Ciforadenant, UGN-301, Viright, MB07133, BOT/BAL, and Lasofoxifene for oncology; Ensifentrine for respiratory disease; QTORIN for rare disease; Sparsentan for kidney disease; VK2809 for hepatology; ANEB-001 for acute cannabinoid intoxication; Reproxalap for opthamology; VK0214 for Rare Disease; and VK5211 for musculoskeletal disorder. The company was incorporated in 1987 and is based in Jupiter, Florida.
| Fecha de pago | Importe por participación |
|---|---|
| 03/04/2007 | 9,3575 USD |
| Fecha | Ratio |
|---|---|
| 02/11/2022 | 1603:1000 |
| 19/11/2010 | 1:6 |
| Fecha | Apertura | Máximo | Mínimo | Cierre | Variación | Volatilidad día | Volumen |
|---|---|---|---|---|---|---|---|
| 23/07/2009 | 10,56 | 11,15 | 10,56 | 11,15 | +5,30% | 5,67% | 176.757 |
| 22/07/2009 | 10,37 | 10,82 | 10,29 | 10,59 | +1,80% | 5,05% | 221.748 |
| 21/07/2009 | 10,89 | 10,89 | 10,41 | 10,41 | -3,47% | 4,47% | 76.730 |
| 20/07/2009 | 10,93 | 11,19 | 10,59 | 10,78 | -0,35% | 5,48% | 65.402 |
| 17/07/2009 | 11,19 | 11,19 | 10,82 | 10,82 | -3,02% | 3,34% | 67.112 |
| 16/07/2009 | 11,12 | 11,23 | 10,70 | 11,15 | -0,67% | 4,71% | 64.574 |
| 15/07/2009 | 10,85 | 11,23 | 10,59 | 11,23 | +4,89% | 5,86% | 93.241 |
| 14/07/2009 | 11,00 | 11,00 | 10,56 | 10,70 | -3,05% | 4,08% | 56.078 |
| 13/07/2009 | 10,67 | 11,04 | 10,48 | 11,04 | +4,24% | 5,26% | 82.367 |
| 10/07/2009 | 10,29 | 10,78 | 10,18 | 10,59 | +2,54% | 5,82% | 66.818 |
| 09/07/2009 | 10,48 | 10,52 | 10,03 | 10,33 | -0,36% | 4,64% | 152.045 |
| 08/07/2009 | 10,59 | 10,70 | 10,26 | 10,37 | -1,77% | 4,24% | 141.037 |
| 07/07/2009 | 10,70 | 10,78 | 10,48 | 10,56 | -1,05% | 2,80% | 61.208 |
| 06/07/2009 | 10,70 | 10,85 | 10,59 | 10,67 | -0,70% | 2,45% | 63.372 |
| 02/07/2009 | 10,85 | 10,97 | 10,59 | 10,74 | -2,71% | 3,45% | 80.203 |
| 01/07/2009 | 10,82 | 11,27 | 10,74 | 11,04 | +3,15% | 4,84% | 172.536 |
| 30/06/2009 | 10,93 | 11,12 | 10,70 | 10,70 | -1,72% | 3,77% | 98.397 |
| 29/06/2009 | 11,15 | 11,23 | 10,70 | 10,89 | -2,35% | 4,70% | 81.326 |
| 26/06/2009 | 10,78 | 11,15 | 10,63 | 11,15 | +3,11% | 4,86% | 795.355 |
| 25/06/2009 | 11,27 | 11,53 | 10,67 | 10,82 | -4,30% | 7,64% | 136.869 |
| 24/06/2009 | 11,30 | 11,42 | 10,97 | 11,30 | +1,00% | 3,97% | 55.250 |
| 23/06/2009 | 11,30 | 11,49 | 10,89 | 11,19 | -0,33% | 5,30% | 105.905 |
| 22/06/2009 | 11,04 | 11,27 | 10,89 | 11,23 | +0,33% | 3,39% | 88.726 |
| 19/06/2009 | 11,30 | 11,30 | 10,63 | 11,19 | +1,36% | 5,96% | 168.181 |
| 18/06/2009 | 10,37 | 11,04 | 10,33 | 11,04 | +6,12% | 6,86% | 81.272 |
| 17/06/2009 | 10,67 | 10,74 | 10,26 | 10,41 | +1,09% | 4,56% | 96.340 |
| 16/06/2009 | 10,56 | 10,85 | 10,29 | 10,29 | -3,85% | 5,32% | 48.704 |
| 15/06/2009 | 11,23 | 11,23 | 10,59 | 10,70 | -4,35% | 5,67% | 54.903 |
| 12/06/2009 | 11,00 | 11,19 | 10,74 | 11,19 | +1,01% | 4,08% | 47.182 |
| 11/06/2009 | 11,34 | 11,34 | 10,89 | 11,08 | -2,63% | 3,96% | 60.273 |